Letter to the Editor: Liver Enzyme Elevation from Atomoxetine Use—A Case Report

Journal of Child and Adolescent PsychopharmacologyVol. 31, No. 4 Letter to the Editor: Liver Enzyme Elevation from Atomoxetine Use—A Case ReportMatthew Abrams, Shirin Hasan, and Anuja MehtaMatthew AbramsAddress correspondence to: Matthew Abrams, BA, Department of Psychiatry, University of Central Florida College of Medicine, 6850 Lake Nona Boulevard, Orlando, FL 32827, USA E-mail Address: mattpabrams@knights.ucf.eduhttps://orcid.org/0000-0001-6059-4857Department of Psychiatry, University of Central Florida College of Medicine, Orlando, Florida, USA.Search for more papers by this author, Shirin HasanDivision of Behavioral Health, Department of Pediatrics, Nemours Children's Hospital, Orlando, Florida, USA.Search for more papers by this author, and Anuja MehtaDepartment of Psychiatry, University of Central Florida College of Medicine, Orlando, Florida, USA.Division of Behavioral Health, Department of Pediatrics, Nemours Children's Hospital, Orlando, Florida, USA.Search for more papers by this authorPublished Online:19 May 2021https://doi.org/10.1089/cap.2021.0014AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Letter to the Editor: Liver Enzyme Elevation from Atomoxetine Use—A Case Report." Journal of Child and Adolescent Psychopharmacology, 31(4), pp. 322–323FiguresReferencesRelatedDetails Volume 31Issue 4May 2021 InformationCopyright 2021, Mary Ann Liebert, Inc., publishersTo cite this article:Matthew Abrams, Shirin Hasan, and Anuja Mehta.Letter to the Editor: Liver Enzyme Elevation from Atomoxetine Use—A Case Report.Journal of Child and Adolescent Psychopharmacology.May 2021.322-323.http://doi.org/10.1089/cap.2021.0014Published in Volume: 31 Issue 4: May 19, 2021Online Ahead of Print:May 7, 2021PDF download